ACS is committed to helping combat the global COVID-19 pandemic with initiatives and free resources. Learn More

Steven Isaacman

Steven Isaacman

Dr. Isaacman founded PHD Biosciences (formerly Nanometics LLC) in 2008, and is responsible for the design and fabrication of several products that are currently sold globally in the personal care and pharmaceutical industry. He has been the Principal Investigator on nine awards that total more than $5 million including: two SBIR awards from the National Cancer Institute, one STTR award from the National Cancer Institute, two SBIR awards from the National Heart Lung and Blood Institute, an Avon Foundation award, and three New York State Center for Advanced Technology awards. At PHD Biosciences, he leads the research team; developing novel small-molecules for the oncology and hematology. Dr. Isaacman received his BS in biochemistry and MS in organic chemistry from Stony Brook University and his Ph.D. in organic chemistry from New York University where his research focused on self-assembling nanoarchitectures for oncology.